share_log

RBC Raises Price Target on Marinus Pharmaceuticals to $24 From $21, Keeps Outperform Rating

RBC Raises Price Target on Marinus Pharmaceuticals to $24 From $21, Keeps Outperform Rating

加拿大皇家銀行將Marinus Pharmicals的目標股價從21美元上調至24美元,維持跑贏大盤的評級
MT Newswires ·  01/03 07:40

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論